Trust CO Of Vermont Abbott Laboratories Transaction History

Trust CO Of Vermont

$2.01 Billion
Q4 2024

A detailed history of Trust CO Of Vermont transactions in Abbott Laboratories stock. As of the latest transaction made, Trust CO Of Vermont holds 199,281 shares of ABT stock, worth $26 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

199,281

Previous 208,881 4.6%

Holding current value

$26 Million

Previous $23.8 Million 5.35%

% of portfolio

1.12%

Previous 1.2%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$111.93 - $119.39 $1.07 Million - $1.15 Million	-9,600 Reduced 4.6%	199,281 $22.5 Million
Q3 2024 Oct 16, 2024	BUY	$100.07 - $118.13 $296,007 - $349,428	2,958 Added 1.44%	208,881 $23.8 Million
Q2 2024 Jul 09, 2024	BUY	$100.73 - $112.44 $501,635 - $559,951	4,980 Added 2.48%	205,923 $21.4 Million
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $3.61 Million - $3.98 Million	32,937 Added 19.6%	200,943 $22.8 Million
Q4 2023 Mar 08, 2024	SELL	$90.19 - $110.4 $1.79 Million - $2.19 Million	-19,823 Reduced 10.55%	168,006 $18.5 Million
Q3 2023 Nov 27, 2023	BUY	$95.53 - $114.62 $1.15 Million - $1.38 Million	12,020 Added 6.84%	187,829 $18.2 Million
Q2 2023 Jul 17, 2023	BUY	$100.78 - $112.29 $673,613 - $750,546	6,684 Added 3.95%	175,809 $19.2 Million
Q1 2023 Apr 07, 2023	BUY	$96.86 - $114.01 $514,714 - $605,849	5,314 Added 3.24%	169,125 $17.1 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $429,481 - $503,847	4,518 Added 2.84%	163,811 $18 Million
Q3 2022 Oct 24, 2022	BUY	$96.76 - $112.03 $161,492 - $186,978	1,669 Added 1.06%	159,293 $15.4 Million
Q2 2022 Jul 20, 2022	BUY	$102.07 - $123.37 $50,728 - $61,314	497 Added 0.32%	157,624 $17.1 Million
Q1 2022 Apr 05, 2022	SELL	$114.02 - $139.04 $46,064 - $56,172	-404 Reduced 0.26%	157,127 $18.6 Million
Q4 2021 Jan 21, 2022	SELL	$115.53 - $141.46 $208,185 - $254,910	-1,802 Reduced 1.13%	157,531 $22.2 Million
Q3 2021 Oct 22, 2021	SELL	$116.66 - $129.06 $11,666 - $12,906	-100 Reduced 0.06%	159,333 $18.8 Million
Q2 2021 Jul 15, 2021	BUY	$105.79 - $124.53 $348,472 - $410,201	3,294 Added 2.11%	159,433 $18.5 Million
Q1 2021 Apr 16, 2021	SELL	$108.84 - $128.23 $141,927 - $167,211	-1,304 Reduced 0.83%	156,139 $18.7 Million
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $122,220 - $133,184	1,164 Added 0.74%	157,443 $17.2 Million
Q3 2020 Nov 06, 2020	SELL	$91.64 - $111.29 $53,701 - $65,215	-586 Reduced 0.37%	156,279 $17 Million
Q2 2020 Jul 17, 2020	SELL	$76.57 - $98.0 $2.46 Million - $3.15 Million	-32,128 Reduced 17.0%	156,865 $14.3 Million
Q1 2020 Apr 24, 2020	BUY	$62.82 - $91.86 $255,426 - $373,502	4,066 Added 2.2%	188,993 $14.9 Million
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $43,573 - $48,507	555 Added 0.3%	184,927 $16.1 Million
Q3 2019 Oct 24, 2019	SELL	$81.84 - $88.74 $391,768 - $424,798	-4,787 Reduced 2.53%	184,372 $15.4 Million
Q2 2019 Jul 26, 2019	SELL	$72.88 - $85.0 $118,575 - $138,295	-1,627 Reduced 0.85%	189,159 $15.9 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $42,380 - $51,238	-640 Reduced 0.33%	190,786 $15.3 Million
Q4 2018 Jan 30, 2019	SELL	$65.56 - $74.27 $193,598 - $219,319	-2,953 Reduced 1.52%	191,426 $13.8 Million
Q3 2018 Oct 26, 2018	BUY	$60.81 - $73.36 $323,144 - $389,835	5,314 Added 2.81%	194,379 $14.3 Million
Q2 2018 Jul 11, 2018	BUY	$57.57 - $63.54 $192,456 - $212,414	3,343 Added 1.8%	189,065 $11.5 Million
Q1 2018 May 18, 2018	BUY	$56.27 - $63.62 $40,964 - $46,315	728 Added 0.39%	185,722 $11.1 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $120,457 - $128,962	2,244 Added 1.23%	184,994 $10.6 Million
Q3 2017 Oct 24, 2017	BUY	$48.06 - $53.64 $8.78 Million - $9.8 Million	182,750	182,750 $9.75 Million

Others Institutions Holding ABT

# of Institutions

3,336

Shares Held

1.36B

Call Options Held

10M

Put Options Held

9.48M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.

Account

Trust CO Of Vermont Abbott Laboratories Transaction History